Floatz logo

GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE)

Ascites Hepatic

Noorik Biopharmaceuticals AGprotein_peptidePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Ascites Hepatic cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Anahita Rabiee MD MHS
Phase 4BB
Empagliflozin
Alexandria University
Phase 2/3BB
Fresh Frozen Plasma
Montefiore Medical Center
Phase 4B
Dapagliflozin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2CCC
URODILATIN
University of Aarhus
Phase 2CCC

View all 11 →

Same molecule, other indications

GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE) is also rated in:

hepatorenal syndromeDormant
A
Indicative ·
84 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
77 / 100
View asset →
esophageal varicesDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →